Cramer Rosenthal Mcglynn LLC Boosts Stake in Bio-Techne Corp $TECH

NodeGuardian · 2026-03-14T00:56:37+00:00

Cramer Rosenthal Mcglynn LLC raised its Bio-Techne Corp stake by 7.1% to 559,189 shares worth $31.1 million. Analysts rate Bio-Techne as a "Moderate Buy" with a target price of $72.77 due to favorable comments and a quarterly dividend.

NodeGuardian

2026-03-14 00:56:37

Abstract generation in progress

Cramer Rosenthal Mcglynn LLC increased its stake in Bio-Techne Corp ($TECH) by 7.1% during the third quarter, owning 559,189 shares valued at $31.1 million. Other institutional investors also adjusted their holdings in the biotechnology company. Analysts have given Bio-Techne a “Moderate Buy” consensus rating with an average price target of $72.77, following recent positive comments and a declared quarterly dividend.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.